Showing 1 - 10 of 1,549
Policymakers on both ends of the political spectrum have been looking for ways to reduce prescription drug prices. Democrats have also been working on expanding healthcare coverage, including different versions of Medicare for All. All these proposals have been framed as issues of access and...
Persistent link: https://www.econbiz.de/10012848087
Drug prices are uniquely susceptible to radical price reductions through generic competition. Patented pharmaceuticals may be priced at more than 30 times the marginal cost of production; the excess is the patent rent collected by the drug company while the patent and exclusive marketing periods...
Persistent link: https://www.econbiz.de/10014060277
Penicillin and other antibiotics were the original wonder drugs and laid the foundation of the modern pharmaceutical industry. Human health significantly improved with the introduction of antibiotics. By 1967, the US Surgeon General declared victory over infectious diseases in the US. But pride...
Persistent link: https://www.econbiz.de/10014060278
While neoclassical economic theory suggests that arbitrage will undermine global differential pricing of pharmaceuticals, the empirical results are more complex. Pharmaceutical regulation, IP laws, global trade agreements, and company policies support differential pricing despite the pressure of...
Persistent link: https://www.econbiz.de/10014070573
It is critical that technology recipients have the prerequisite knowledge and scientific base to best exploit the information. This includes domestic private and public research laboratories and universities, in addition to a sound basis of technical skills and human capital. Each of these may...
Persistent link: https://www.econbiz.de/10014157538
During the past decade the federal governments of emerging market ‘BRICS’ (Brazil, Russia, India, China, South Africa) nations have determined that the shortest path to an industrialized and innovative economy is via the institutional conversion of privately conceived, developed and...
Persistent link: https://www.econbiz.de/10014186101
High technology innovators and investors operating in the life sciences, clean energy and information and communication technology sectors face complex economic and legal uncertainties compounded by regulatory and policy risks during the course of guiding an innovative concept from its research...
Persistent link: https://www.econbiz.de/10014188405
The regulatory environment in a country is an important factor that affects firm performance. This study investigates the impact of a particular regulation - license requirements for certain firm activities - on the innovation performance of Indian firms in the 1990s. Using a unique firm-level...
Persistent link: https://www.econbiz.de/10013373854
The regulatory environment in a country is an important factor that affects firm performance. This study investigates the impact of a particular regulation - license requirements for certain firm activities - on the innovation performance of Indian firms in the 1990s. Using a unique firm-level...
Persistent link: https://www.econbiz.de/10012795831
The challenge of achieving socially optimal incentives for innovation in public goods faces twin market failures: a market failure to adequately promote public goods invention and a market failure to implement innovative public goods once developed. Though innovation in private goods sometimes...
Persistent link: https://www.econbiz.de/10012991630